NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND β2-AGONIST OF INDACATEROL: PROSPECTS OF COBD THERAPY

The therapy by fixed combinations, LABA/LAACD on the basis of indacaterol and glycopyrronium bromide is characterized by a high clinical efficacy compared to monocomponents of the product, tiotropium, and a fixed combination of LABA/iCGS. The results of the clinical studies confirm the pharmacologic...

Deskribapen osoa

Xehetasun bibliografikoak

Egile nagusia:	S. N. AVDEEV
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	Remedium Group LLC 2016-12-01
Saila:	Медицинский совет
Gaiak:	copd bronchodilators fixed combination s long-acting anticholinergics long-acting β2-agonists indacaterol glycopyrronium bromide
Sarrera elektronikoa:	https://www.med-sovet.pro/jour/article/view/1556
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!